本文選題：噬血細(xì)胞 + 淋巴組織細(xì)胞增生癥��； 參考：《遼寧中醫(yī)雜志》2011年09期

【摘要】：目的:探討噬血細(xì)胞性淋巴組織細(xì)胞增生征的病因、臨床特征及中西醫(yī)結(jié)合治療。方法:回顧性分析2008年4月—2010年9月確診的9例HLH患者。結(jié)果:9例患者中有5例與感染相關(guān),其中4例為EB病毒感染相關(guān),4例為腫瘤相關(guān),臨床表現(xiàn)均符合HLH-2004診斷標(biāo)準(zhǔn),本病屬祖國(guó)醫(yī)學(xué)溫病中伏邪溫病的范疇。經(jīng)中西醫(yī)結(jié)合治療,存活4例,死亡5例。結(jié)論:HLH病因復(fù)雜,臨床表現(xiàn)多樣,病情兇險(xiǎn),死亡率高,及早診斷和中西醫(yī)聯(lián)合治療可改善預(yù)后。
[Abstract]:Objective: to investigate the etiology, clinical features and treatment of hemophagocytic lymphohistiocytosis. Methods: 9 cases of HLH diagnosed from April 2008 to September 2010 were retrospectively analyzed. Results among 9 cases, 5 cases were related to infection, 4 cases were associated with EBV infection and 4 cases were tumor-related. All clinical manifestations were in accordance with HLH-2004 diagnostic criteria. The disease belongs to the category of latent febrile disease in Chinese medical febrile disease. 4 cases survived and 5 cases died after treatment with integrated traditional Chinese and western medicine. Conclusion the etiology of the disease is complicated, the clinical manifestations are diverse, the disease is dangerous and the mortality is high. Early diagnosis and combined treatment of traditional Chinese and western medicine can improve the prognosis.
【作者單位】： 南京中醫(yī)藥大學(xué)附屬醫(yī)院血液科;
【分類(lèi)號(hào)】：R55

【相似文獻(xiàn)】

相關(guān)期刊論文 前10條

1 張文曦;孫雪梅;徐祖瓊;;中西醫(yī)結(jié)合治療噬血細(xì)胞性淋巴組織細(xì)胞增生征[J];遼寧中醫(yī)雜志;2011年09期

2 ;[J];;年期

3 ;[J];;年期

4 ;[J];;年期

5 ;[J];;年期

6 ;[J];;年期

7 ;[J];;年期

8 ;[J];;年期

9 ;[J];;年期

10 ;[J];;年期

，

本文編號(hào)：2038789